Find the investors funding Health Seed rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
France's AbTx raises €1.7M seed for miniaturised cancer antibodies - Dealroom
AbTx is a French biotechnology startup founded in 2024, developing a new generation of antibody-drug conjugates (ADCs) for solid tumors. Their patented Therano-Stick platform uses enzymatic bio-conjugation to create miniaturized ADCs called fragment drug conjugates (FDCs). This seed round aims to validate their novel platform in the competitive ADC field.
France's AbTx raises €1.7M seed for miniaturised cancer antibodies Dealroom
You just read who funded AbTx. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.